• #953 Fortune 1000 Revenue Rank

Incyte Corporation

Incyte
1801 Augustine Cut Off
Wilmington, DE, 19803-4404  United States
(302) 498-6700
Company Type: Corporation Parent

D&B Business Directory

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. It is focused on developing and selling drugs that inhibit specific enzymes associated with cancer and other diseases. The company's lead program is its JAK (Janus associated kinase) inhibitor program. Its first commercial product, Jakafi, is approved for treatment of polycythemia vera and myelofibrosis (two rare blood cancers) and graft-versus-host-disease in the US; partner Novartis markets the drug internationally. Another inhibitor drug, Iclusig, is marketed for certain forms of leukemia in Europe. Incyte has a number of product candidates in research and clinical development stages, partially through partnerships with other drugmakers, for various cancers, inflammatory ailments, and other conditions.

Try D&B Hoovers Free
Corporation Parent
Doing Business As
Incyte
Website
Address
1801 Augustine Cut Off
Wilmington ​, DE, 19803-4404
United States
See other locations
Phone
(302) 498-6700
Company Description

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. It is focused on developing and selling drugs that inhibit specific enzymes associated with cancer and other diseases. The company's lead program is its JAK (Janus associated kinase) inhibitor program. Its first commercial product, Jakafi, is approved for treatment of polycythemia vera and myelofibrosis (two rare blood cancers) and graft-versus-host-disease in the US; partner Novartis markets the drug internationally. Another inhibitor drug, Iclusig, is marketed for certain forms of leukemia in Europe. Incyte has a number of product candidates in research and clinical development stages, partially through partnerships with other drugmakers, for various cancers, inflammatory ailments, and other conditions.

Key Principal
Herve Hoppenot See more contacts
Ranking
#953 Fortune 1000 Revenue Rank
D&B Hoovers Logo

For dynamic search and list-building capabilities, real-time trigger alerts, comprehensive company profiles, and valuable research and technology reports try D&B Hoovers for free!

Financial Statements

Financial data as of December 31, 2020 (12 month period) in USD

Annual Revenue2020
$2.67 billion USD

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (All Sites) 1,773
  • ASSETS (MIL USD) 3,561
  •  REVENUE (MIL USD) 2,666.7
  • TICKER SYMBOL INCY
  • Year Started 1991
  • Incorporated 1991
  • FISCAL YEAR END DEC
  • SALES GROWTH % 23.53%

Get in Touch with 5 Principals* and 798 Contacts

A D&B Hoovers Subscription is your foot in the door to Incyte Corporation contact information.
  • Herve Hoppenot
    Chairman of the Board and President and Chief Executive Officer
  • CHRISTIANA STAMOULIS
    Executive Vice President and Chief Financial Officer
  • DASHYANT DHANAK
    Executive Vice President and Officer
  • STEVEN STEIN
    Executive Vice President and Officer

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

Free Install

Related Products

Grow Business FasterLearn More
D&B Finance Analytics Credit IntelligenceIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Incyte Corporation

Incyte Corporation*

5
Principals
See who the company's key decision makers are
798
Contacts
Reach the right people with access to detailed contact information.
6
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.